文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

夏威夷2016年淋球菌簇:高水平阿奇霉素耐药且头孢曲松敏感性下降

Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
PubMed 文献 · Clin Infect Dis · 2017-01-01

2016年4-5月夏威夷瓦胡岛7例患者分离出8株淋球菌,均对阿奇霉素高水平耐药(琼脂稀释MIC>16 μg/mL),其中5株头孢曲松MIC=0.125 μg/mL,所有菌株产β-内酰胺酶且对青霉素、四环素和环丙沙星耐药,基因组分析显示遗传相关性,患者均无近期旅行或抗生素使用史,均治疗成功。

要点

  • 夏威夷出现遗传相关淋球菌簇,高水平阿奇霉素耐药且头孢曲松敏感性下降。
  • 所有菌株产β-内酰胺酶,对青霉素、四环素和环丙沙星耐药。
  • 患者无近期旅行或抗生素使用史,提示本地传播,均治疗成功。

核心结论

  • 该遗传相关淋球菌簇对头孢曲松敏感性下降且高水平阿奇霉素耐药,可能使美国当前推荐双疗法治疗失败的风险更近一步。

研究设计与样本

  • 2016年4月21日至5月10日夏威夷瓦胡岛7例患者分离的8株淋球菌,经州卫生部门Etest初筛后送华盛顿大学和CDC行琼脂稀释确认及基因组分析。

主要发现

  • Etest显示所有菌株阿奇霉素MIC>256 μg/mL且头孢曲松MIC≥0.125 μg/mL。
  • 琼脂稀释确认所有菌株阿奇霉素MIC>16 μg/mL,5株头孢曲松MIC=0.125 μg/mL。
  • 所有菌株产β-内酰胺酶,对青霉素、四环素和环丙沙星耐药。
  • 基因组分析揭示菌株间遗传相关。
  • 无患者报告近期旅行或抗生素使用,无男性患者报告男性性伴,所有患者治疗成功。

临床怎么用

  • 对淋球菌感染应关注阿奇霉素高水平耐药和头孢曲松敏感性下降,当前推荐的双疗法可能面临治疗失败风险。
  • 发现类似耐药菌株时应进行确认药敏试验和基因组分析,并追踪性伴。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Centers for Disease Control and Prevention (CDC) currently recommends dual therapy with ceftriaxone and azithromycin for gonorrhea to ensure effective treatment and slow emergence of antimicrobial resistance. Since 2013, the prevalence of reduced azithromycin susceptibility increased in the United States; however, these strains were highly susceptible to cephalosporins. We identified a cluster of Neisseria gonorrhoeae isolates with high-level azithromycin resistance, several of which also demonstrated decreased ceftriaxone susceptibility. METHODS: Eight N. gonorrhoeae isolates collected from 7 patients on Oahu, Hawaii, seen 21 April 2016 through 10 May 2016 underwent routine Etest antimicrobial susceptibility testing by the Hawaii Department of Health. All demonstrated elevated azithromycin minimum inhibitory concentrations (MICs) >256 μg/mL and elevated ceftriaxone MICs (≥0.125 μg/mL). Isolates were sent to the University of Washington and CDC for confirmatory agar dilution testing; sequence data were sent to CDC for analysis. All patients were interviewed and treated, and when possible, partners were interviewed, tested, and treated. RESULTS: All isolates had azithromycin MICs >16 µg/mL and 5 had ceftriaxone MICs = 0.125 µg/mL by agar dilution. All isolates were β-lactamase positive and were resistant to penicillin, tetracycline, and ciprofloxacin. Genomic analysis revealed genetic relatedness. No patients reported recent travel or antibiotic use, and no male patients reported male sex partners. All patients were successfully treated. CONCLUSIONS: This cluster of genetically related gonococcal isolates with decreased ceftriaxone susceptibility and high-level azithromycin resistance may bring the threat of treatment failure in the United States with the current recommended dual therapy one step closer.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Katz AR, Komeya AY, Kirkcaldy RD, et al. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016. Clin Infect Dis. 2017. PMID: 28549097. doi:10.1093/cid/cix485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。